India's benchmark indexes are likely to open little changed on Tuesday, after logging their best day in more than four years ...

Pharma stocks lit up Dalal Street on Tuesday as President Donald Trumps remarks on drug pricing sent mixed signals to global ...

Pharma stocks rise amid market drop due to limited impact from US pricing order. Discover more on what fuels this trend.

US President Trump's move to cut drug prices by 30–80% may severely impact Indian pharma exports and profitability, ...

Pharma stocks faced a downturn after US President Donald Trump revealed plans to slash drug prices. Sun Pharmaceuticals and ...

Indian Pharma stocks were on a strong uptrend today, with the Nifty Pharma index rising by 1.19% in intraday trade.

The sudden focus on pharmaceutical shares is due to a new executive order signed by US President Donald Trump on Monday.

The spotlight is on pharmaceutical stocks after Donald Trump signed a wide-reaching executive order on Monday, directing ...

President Trump plans to sign an executive order mandating drugmakers to align U.S. drug prices with those of other countries ...

On May 13, 2025, the domestic markets witnessed a sharp decline, with the BSE Sensex dropping 1.55 per cent to close at ...

Pharma stocks were trading higher on May 13 after better-than-feared Donald Trump’s executive order on pharma last night.

Information technology and pharma sector, Tata Steel Ltd., and Hindalco Ltd. were among the top companies on brokerages' ...